Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: A preliminary report

Clinical and Investigative Medicine

Volumn 31, Issue 6, 2008, Pages

  Gao, Heng Qiang ^a   Zhu, Hai Yan ^a   Zhang, Yan Qiang ^a   Wang, Le Xin ^b  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MALE; POST STROKE DEPRESSION; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; STROKE;

AGED; CHI-SQUARE DISTRIBUTION; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTONIN; STROKE; TIME FACTORS;

EID: 57049131070     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kotila M, Numminen H, Waltimo O, Kaste M. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol 1999;6:309-12.
2. Chemerinski E, Robinson RG. The neuropsychiatry of stroke. Psychosomatics 2000;41:5-14.
3. Barker-Collo SL. Depression and anxiety 3 months post stroke: prevalence and correlates. Arch Clin Neuropsychol 2007; 22:519-31.
4. van de Port IG, Kwakkel G., Bruin M, Lindeman E. Determinants of depression in chronic stroke: a prospective cohort study. Disabil Rehabil 2007;29:353-8.
5. Morris PL, Robinson RG, de Carvalho ML, et al. Lesion characteristics and depressed mood in the stroke data bank study. J Neuropsychiatry Clin Neurosci 1996;8:153-9.
6. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry 1999;45:187-92.
7. Grasso MG, Pantano P, Ricci M, et al. Mesial temporal cortex hypoperfusion is associated with depression in subcortical stroke. Stroke 1994;25:980-5.
8. Bryer JB, Starkstein SE, Votypka V, Parikh RM. Price TR. Robinson RG. Reduction of CSF monoamine metabolites in poststroke depression: a prelimnary report. J Neuropsychiatry 1992;4:440-2.
9. Meltzer HY, Lowy MT. Serotonin in hypothesis of depression. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York, NY: Raven Press, 1987;513-26.
10. Cheng FC, Kuo JS, Chang WH, Juang DJ, Shih Y, Lai JS. Rapid and reliable high-performance liquid chromatographic method for analyzing human plasma 5-HT, 5-hydroxyindoleacetic acid, homovanillic acid and 3,4-dihydroxyphenylacetic acid. J Chromatogr 1993; 617:227-32.
11. th ed. New York, NY: Churchill Livingston, 2007:189-92.
12. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001;7:541-7.
13. Li MS, Cheng FC, Yeh HZ, Lio TY, Liu JH. Determination of plasma serotonin and 5-Hydroxyindoleacetic acid in healthy subjects and cancer patients. Clin Chem 2000;46:422-3.
14. Neumeister A, Praschak-Rieder N, Hesselmann B, et al. Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation. Arch Gen Psychiatry 1998;55:167-72.
15. Hou C, Jia F, Liu Y, Li L. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res 2006;1095:154-8.
16. Barton DA, Esler MD, Dawood T, et al. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry 2008;65:38-46.
17. Geracioti TD Jr, Loosen PT, Ekhator NN, et al. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling. Depress Anxiety 1997;6:89-94.
18. Sullivan GM, Oquendo MA, Huang YY, Mann JJ. Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. Int J Neuropsychopharmacol 2006;9:547-56.
19. Rampello L, Chiechio S, Nicoletti G, et al. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology 2004;173:73-8.
20. Starkstein SE, Mizrahi R, Power BD. Antidepressant therapy in post-stroke depression. Expert Opin Pharmacother 2008;9:1291-8.
21. Bilge C, Kocer E, Kocer A, Turk Boru U. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med 2008;44:13-8.